Carroll Financial Associates’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | $17K | Hold |
225
| – | – | ﹤0.01% | 1013 |
|
|
2021
Q3 | $25K | Hold |
225
| – | – | ﹤0.01% | 938 |
|
|
2021
Q2 | $36K | Sell |
225
-494
| -69% | -$79K | ﹤0.01% | 901 |
|
|
2021
Q1 | $87K | Sell |
719
-31
| -4% | -$3.75K | 0.01% | 604 |
|
|
2020
Q4 | $114K | Hold |
750
| – | – | 0.01% | 491 |
|
|
2020
Q3 | $62K | Sell |
750
-150
| -17% | -$12.4K | ﹤0.01% | 597 |
|
|
2020
Q2 | $66K | Buy |
900
+450
| +100% | +$33K | 0.01% | 583 |
|
|
2020
Q1 | $19K | Hold |
450
| – | – | ﹤0.01% | 787 |
|
|
2019
Q4 | $27K | Hold |
450
| – | – | ﹤0.01% | 800 |
|
|
2019
Q3 | $18K | Hold |
450
| – | – | ﹤0.01% | 854 |
|
|
2019
Q2 | $21K | Hold |
450
| – | – | ﹤0.01% | 810 |
|
|
2019
Q1 | $16K | Hold |
450
| – | – | ﹤0.01% | 802 |
|
|
2018
Q4 | $15K | Hold |
450
| – | – | ﹤0.01% | 742 |
|
|
2018
Q3 | $19K | Hold |
450
| – | – | ﹤0.01% | 714 |
|
|
2018
Q2 | $26K | Hold |
450
| – | – | ﹤0.01% | 614 |
|
|
2018
Q1 | $20K | Hold |
450
| – | – | ﹤0.01% | 668 |
|
|
2017
Q4 | $10K | Hold |
450
| – | – | ﹤0.01% | 822 |
|
|
2017
Q3 | $8K | Hold |
450
| – | – | ﹤0.01% | 858 |
|
|
2017
Q2 | $7K | Hold |
450
| – | – | ﹤0.01% | 905 |
|
|
2017
Q1 | $9K | Buy |
+450
| New | +$9K | ﹤0.01% | 856 |
|